Patients with refractory large B-cell lymphoma who were treated with axicabtagene ciloleucel (axi-cel; Yescarta) had a 3-year overall survival (OS) rate of 47%, according to an updated analysis of the phase II ZUMA-1 trial. The median duration of follow-up …
See Original Article
The future of the U.S. wireless industry hinges on a court battle kicking off Monday in federal court in Manhattan, a case that could end with T-Mobile
See Original Article
As U.S.-China trade talks undergo more advances and setbacks than a ping-pong match, South Carolina businessman John Ling is increasingly
See Original Article
The human element was the main cause of accidents, accounting for 76.8 percent of total accidents in 2018, followed by vehicles accounting for 15.7
See Original Article
SIMI VALLEY, Calif. â Amazon CEO and founder Jeff Bezos gave a dismal outlook for the nation if U.S. tech companies decide to not support the Pentagon’s war business. âIf big tech is going to turn their backs on the Department of Defense, this country is in …
See Original Article
Leave a Reply